Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201103308 Principal Investigator: Linette, Gerald
Title: Mature Dendritic Vaccination Against gp100 in Patients with Advanced Melanoma
Description: You may be asked to participate in this study because you have been diagnosed with metastatic melanoma. Although there are treatments that can control your disease for a period of time, there are no treatments that have been shown to cure melanoma once it has spread to distant sites in the body (su...MORE
___________________________________________________________________________________________________
 Number: 201503037 Principal Investigator: Linette, Gerald
Title: A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy with Nivolumab versus Ipilimumab after Complete Resection of Stage IIIb/c or Stage IV Melanoma in Subjects who are at High Risk for Recurrence
Description: The purpose of this research study is to test the effectiveness, safety, and tolerability of an investigational drug called nivolumab compared to ipilimumab....MORE
___________________________________________________________________________________________________
 Number: 201411099 Principal Investigator: Linette, Gerald
Title: A Phase 3b, Multicenter, Open-label, Single-arm, Expanded Access Protocol of Talimogene Laherparepvec for the Treatment of Subjects With Unresected, Stage lllB to IVM1c Melanoma
Description: The purpose of this research study is to provide talimogene laherparepvec, the study drug, to people with advanced melanoma....MORE
___________________________________________________________________________________________________
 Number: 201408145 Principal Investigator: Linette, Gerald
Title: A Phase II, open-label, multicenter trial to investigate the clinical activity and safety of MSB0010718C in subjects with Merkel cell carcinoma
Description: The purpose of this study is to evaluate how well patients with Merkel cell carcinoma respond to MSB0010718C....MORE
___________________________________________________________________________________________________
 Number: 201205056 Principal Investigator: Linette, Gerald
Title: A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients with a High Risk of Recurrence
Description: The purpose of this study is to determine how safe and how well POL-103A works in preventing the relapse of melanoma after patients have undergone surgery....MORE
___________________________________________________________________________________________________
 Number: 201010741 Principal Investigator: Linette, Gerald
Title: Phase I/II study to assess the safety and activity of enhanced TCR transduced autologous T cells against cancer-testis antigens in metastatic melanoma
Description: The purpose of this clinical trial is to assess the effects (both good and bad) of chemotherapy and treatment with modified T cells on cancer and general health....MORE
___________________________________________________________________________________________________
 Number: 201105020 Principal Investigator: Anadkat, Milan
Title: Retrospective and Prospective Data Collection and Analysis of Cutaneous Chemotherapy REACTions at Washington University
___________________________________________________________________________________________________
 Number: 201307042 Principal Investigator: Lockhart, A. Craig
Title: An Open-Label, Phase 1/Phase 2, Single-Agent Study of CEP-32496 in Patients with Advanced Solid Tumors in Phase 1 and in Patients with Advanced Melanoma and Metastatic Colorectal Cancer with BRAF Mutation in Phase 2
Description: This research study has two parts. Phase 1 of the research study will include patients with advanced solid tumors for which there are no established standard therapies or who do not tolerate standard therapies well, and Phase 2 will include patients with advanced melanoma or advanced colorectal canc...MORE
___________________________________________________________________________________________________